Fate Therapeutics
FATE
#8988
Rank
$0.12 B
Marketcap
$1.08
Share price
1.89%
Change (1 day)
17.39%
Change (1 year)

Fate Therapeutics (FATE) Fails to deliver data

Key failure to deliver metrics for Fate Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Fate Therapeutics (FATE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Fate Therapeutics (FATE) - since 2013

Volume in USD (price x number of shares), data since 2013

Fate Therapeutics (FATE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026$0 M-99.36%
2025$1.38 M14.86%
2024$1.2 M-44.15%
2023$2.15 M-89.19%
2022$19.92 M-20.28%
2021$24.99 M31.2%
2020$19.05 M9.95%
2019$17.32 M59.52%
2018$10.86 M1415.4%
2017$0.71 M181.93%
2016$0.25 M-79.05%
2015$1.21 M-17.49%
2014$1.47 M-81.78%
2013$8.07 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Becton Dickinson
BDX
$2.11 M$96.11 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
$4.82 M$23.17 M๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
$13.79 M$18.9 M๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$4.98 M$27.54 M๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
$15.02 M$47.22 M๐Ÿ‡บ๐Ÿ‡ธ USA